Showing results (71-80 of 119) with videos related to
Sort By:
Pageof 12
Proceedings of the National Academy of Sciences of the United States of America|October 11, 2002
Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's diseaseB Urbanc, L Cruz, R Le, et al.Journal of Cell Science|October 7, 2004
Demonstration of BACE (beta-secretase) phosphorylation and its interaction with GGA1 in cells by fluorescence-lifetime imaging microscopyChristine A F von Arnim, Michelle M Tangredi, Ithan D Peltan, et al.Parkinsonism & Related Disorders|September 12, 2018
Severity dependent distribution of impairments in PSP and CBS: Interactive visualizationsClaire Brittain, Andrew McCarthy, Michael C Irizarry, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 31, 2025
Combining CSF MTBR-tau243 and plasma pTau217 ratio enhances the prediction of continuous regional tau PET burden in early Alzheimer's diseaseViswanath Devanarayan, Kanta Horie, Kristin Wildsmith, et al.Alzheimer'S & Dementia (New York, N. Y.)|January 3, 2025
Alzheimer's disease drug development in an evolving therapeutic landscapeStacie Weninger, Michael C Irizarry, Adam S Fleisher, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 2, 2012
The epidemiology of Alzheimer's disease: laying the foundation for drug design, conduct, and analysis of clinical trialsKristine Yaffe, Michael Tocco, Ronald C Petersen, et al.The American Journal of Pathology|July 6, 2000
Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal lossA Takeuchi, M C Irizarry, K Duff, et al.Journal of Neuropathology and Experimental Neurology|August 7, 2001
Plaque-induced abnormalities in neurite geometry in transgenic models of Alzheimer disease: implications for neural system disruptionR Le, L Cruz, B Urbanc, et al.Alzheimer'S Research & Therapy|December 11, 2012
Plasma lipoprotein-associated phospholipase A2 activity in Alzheimer's disease, amnestic mild cognitive impairment, and cognitively healthy elderly subjects: a cross-sectional studyJulie E Davidson, Andrew Lockhart, Leslie Amos, et al.Neuro-Degenerative Diseases|August 16, 2006
Prevalence and effects of lobar microhemorrhages in early-stage dementiaAlireza Atri, Joseph J Locascio, Jenny M Lin, et al.Pageof 12